List of Excipients in API DEFERASIROX
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DEFERASIROX
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | CELLULOSE, MICROCRYSTALLINE | |
Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | CROSPOVIDONE | |
Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | LACTOSE MONOHYDRATE | |
Novartis Pharmaceuticals Corporation | EXJADE | deferasirox | 0078-0468 | MAGNESIUM STEARATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing DEFERASIROX
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 | CROSPOVIDONE |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 | FD&C BLUE NO. 2--ALUMINUM LAKE |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 | FD&C RED NO. 40 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 | HYPROMELLOSE 2910 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for DEFERASIROX
Excipient focus: CASTOR OIL
DEFERASIROX drug variants containing CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-200 |
Novadoz Pharmaceuticals LLC | deferasirox | 72205-076 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
DEFERASIROX drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Actavis Pharma Inc | deferasirox | 0591-4730 |
Camber Pharmaceuticals Inc | deferasirox | 31722-030 |
Alembic Pharmaceuticals Limited | deferasirox | 46708-324 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
DEFERASIROX drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Northstar Rx LLC | deferasirox | 16714-993 |
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
Dr Reddy's Laboratories Inc | deferasirox | 43598-855 |
Alembic Pharmaceuticals Limited | deferasirox | 46708-324 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
DEFERASIROX drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Northstar Rx LLC | deferasirox | 16714-993 |
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-200 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
DEFERASIROX drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | deferasirox | 46708-410 |
Sun Pharmaceutical Industries Inc | deferasirox | 57664-768 |
Aurobindo Pharma Limited | deferasirox | 59651-410 |
Alembic Pharmaceuticals Inc | deferasirox | 62332-410 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
DEFERASIROX drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Xiromed LLC | deferasirox | 70700-269 |
CELLTRION USA INC | deferasirox | 72606-013 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
DEFERASIROX drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
DEFERASIROX drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
DEFERASIROX drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Cipla USA Inc | deferasirox | 69097-391 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
DEFERASIROX drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROGENATED CASTOR OIL
DEFERASIROX drug variants containing HYDROGENATED CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Ascend Laboratories LLC | deferasirox | 67877-549 |
Ascend Laboratories LLC | deferasirox | 67877-552 |
Ascend Laboratories LLC | deferasirox oral | 67877-675 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing HYDROGENATED CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
DEFERASIROX drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
Bionpharma Inc | deferasirox | 69452-159 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-200 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
DEFERASIROX drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | deferasirox | 46708-410 |
Alembic Pharmaceuticals Inc | deferasirox | 62332-410 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
DEFERASIROX drug variants containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Amneal Pharmaceuticals NY LLC | deferasirox | 69238-1486 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
DEFERASIROX drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Northstar Rx LLC | deferasirox | 16714-993 |
Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
Sun Pharmaceutical Industries Inc | deferasirox | 57664-768 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
DEFERASIROX drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
DEFERASIROX drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-4730 |
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
Northstar Rx LLC | deferasirox | 16714-993 |
>Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
DEFERASIROX drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Ascend Laboratories LLC | deferasirox | 67877-549 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
DEFERASIROX drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
Camber Pharmaceuticals Inc | deferasirox | 31722-030 |
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
Ascend Laboratories LLC | deferasirox | 67877-552 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
DEFERASIROX drug variants containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Actavis Pharma Inc | deferasirox | 0591-4730 |
Camber Pharmaceuticals Inc | deferasirox | 31722-030 |
Aurobindo Pharma Limited | deferasirox | 59651-410 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
DEFERASIROX drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Aurobindo Pharma Limited | deferasirox | 59651-410 |
Ascend Laboratories LLC | deferasirox | 67877-549 |
NorthStar Rx LLC | deferasirox | 72603-231 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 200
DEFERASIROX drug variants containing MICROCRYSTALLINE CELLULOSE 200
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | deferasirox | 31722-030 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing MICROCRYSTALLINE CELLULOSE 200
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 188
DEFERASIROX drug variants containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
Actavis Pharma Inc | deferasirox | 0591-4730 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLOXAMER 188
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Northstar Rx LLC | deferasirox | 16714-993 |
Dr Reddy's Laboratories Inc | deferasirox | 43598-855 |
>Company | >Ingredient | >NDC |
Excipient focus: POLOXAMER 407
DEFERASIROX drug variants containing POLOXAMER 407
Company | Ingredient | NDC |
---|---|---|
Northstar Rx LLC | deferasirox | 16714-993 |
Zydus Pharmaceuticals USA Inc | deferasirox | 70710-1275 |
Zydus Lifesciences Limited | deferasirox | 70771-1471 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLOXAMER 407
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
DEFERASIROX drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | deferasirox | 46708-410 |
Alembic Pharmaceuticals Inc | deferasirox | 62332-410 |
Ascend Laboratories LLC | deferasirox | 67877-552 |
Amneal Pharmaceuticals NY LLC | deferasirox | 69238-1486 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
DEFERASIROX drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | deferasirox | 0591-3853 |
CELLTRION USA INC | deferasirox | 72606-013 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
DEFERASIROX drug variants containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Sun Pharmaceutical Industries Inc | deferasirox | 57664-768 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
DEFERASIROX drug variants containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
Aurobindo Pharma Limited | deferasirox | 59651-410 |
Xiromed LLC | deferasirox | 70700-269 |
NorthStar Rx LLC | deferasirox | 72603-231 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
DEFERASIROX drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Northstar Rx LLC | deferasirox | 16714-993 |
Cipla USA Inc | deferasirox | 69097-391 |
Zydus Pharmaceuticals USA Inc | deferasirox | 70710-1275 |
Zydus Lifesciences Limited | deferasirox | 70771-1471 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
DEFERASIROX drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
CELLTRION USA INC | deferasirox | 72606-013 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
DEFERASIROX drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
DEFERASIROX drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | deferasirox | 0591-3853 |
Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
EPIC PHARMA LLC | deferasirox | 42806-371 |
Actavis Pharma Inc | deferasirox | 45963-454 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
DEFERASIROX drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | deferasirox | 0591-3853 |
Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
EPIC PHARMA LLC | deferasirox | 42806-371 |
Actavis Pharma Inc | deferasirox | 45963-454 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
DEFERASIROX drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
MSN LABORATORIES PRIVATE LIMITED | deferasirox | 69539-073 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
DEFERASIROX drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Cipla USA Inc | deferasirox | 69097-391 |
Cipla USA Inc | deferasirox | 69097-550 |
Xiromed LLC | deferasirox | 70700-269 |
CELLTRION USA INC | deferasirox | 72606-013 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
DEFERASIROX drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Ascend Laboratories LLC | deferasirox | 67877-552 |
Ascend Laboratories LLC | deferasirox oral | 67877-675 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
DEFERASIROX drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Dr Reddy's Laboratories Inc | deferasirox | 43598-855 |
Actavis Pharma Inc | deferasirox | 45963-454 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
Actavis Pharma Inc | deferasirox | 0591-4730 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
DEFERASIROX drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Ascend Laboratories LLC | deferasirox | 67877-549 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
DEFERASIROX drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | deferasirox | 46708-324 |
Alembic Pharmaceuticals Limited | deferasirox | 46708-410 |
Alembic Pharmaceuticals Inc | deferasirox | 62332-324 |
Alembic Pharmaceuticals Inc | deferasirox | 62332-410 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
DEFERASIROX drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
Camber Pharmaceuticals Inc | deferasirox | 31722-030 |
Dr Reddy's Laboratories Inc | deferasirox | 43598-853 |
Ascend Laboratories LLC | deferasirox | 67877-552 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
DEFERASIROX drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
Northstar Rx LLC | deferasirox | 16714-993 |
Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-4730 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
DEFERASIROX drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
Northstar Rx LLC | deferasirox | 16714-993 |
Camber Pharmaceuticals Inc | deferasirox | 31722-011 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-4730 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
DEFERASIROX drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | deferasirox | 0093-3517 |
>Company | >Ingredient | >NDC |
DEFERASIROX drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0468 |
Novartis Pharmaceuticals Corporation | deferasirox | 0078-0654 |
Teva Pharmaceuticals Inc | deferasirox | 0480-7011 |
Actavis Pharma Inc | deferasirox | 0591-3853 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.